Progress towards the 'Golden Age' of biotechnology

Current Opinion in Biotechnology

Volumn 24, Issue SUPPL.1, 2013, Pages

  Gartland, K M A ^a   Bruschi, F ^b   Dundar, M ^c   Gahan, P B ^d   Viola Magni, M P ^e   Akbarova, Y ^c  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF PISA   (Italy)

^c Faculty of Medicine   (Turkey)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e Research Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTIONS; BIOTECHNOLOGICAL APPLICATIONS; CLIMATE CHANGE ADAPTATION; CROSS-CUTTING TECHNOLOGY; GENETIC MODIFICATIONS; GLOBAL ECONOMIC GROWTH; GREEN BIOTECHNOLOGIES; PERSONALIZED MEDICINES;

BIOINFORMATICS; CROPS; CUTTING TOOLS; DIAGNOSIS; DISEASES; FEEDSTOCKS; FOOD SUPPLY; GOLD; NUCLEIC ACIDS; SOAPS (DETERGENTS);

BIOTECHNOLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; CARBOHYDRATE; INFLUENZA VACCINE; NUCLEIC ACID; PROTEIN; VACCINE; ZIDOVUDINE;

ADAPTATION; ARTICLE; BACTERIAL INFECTION; BIOENERGY; BIOINFORMATICS; BIOTECHNOLOGY; COLD TOLERANCE; DNA MODIFICATION; DROUGHT RESISTANCE; EPIGENETICS; EXPERIMENTAL MODEL; FOOD INDUSTRY; FOOD SECURITY; GENETIC DISORDER; HUMAN; IMMUNOTHERAPY; LOW TEMPERATURE; NONHUMAN; PERSONALIZED MEDICINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHIZOBIUM; RICE; TRANSCRIPTOMICS;

AGRICULTURE; ANIMALS; ANTIMALARIALS; BIOFUELS; BIOTECHNOLOGY; CARBOHYDRATES; CLIMATE CHANGE; DROUGHTS; ENVIRONMENT; EPIGENOMICS; FOOD SUPPLY; HUMANS; PLASTICS; PROTEINS;

AGROBACTERIUM; BACTERIA (MICROORGANISMS);

EID: 84883052365     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2013.05.011     Document Type: Article

References (80)

1. Ecker J.R., Bickmore W.A., Barroso I., Pritchard J.K., Gilad Y., Segai E. Genomics: ENCODE explained. Nature 2012, 489:52-55.
2. Sanyal A., Lajoie B.R., Jain G., Dekker J. The long-range interaction landscape of gene promoters. Nature 2012, 489:109-113.
3. Ordonez M.P., Goldstein L.S.B. Using human-induced pluripotent stem cells to model monogenic metabolic disorders of the liver. Semin Liver Dis 2012, 32:298-306.
4. Akbarian S., Halene T. The neuroepigenetics of suicide. Am J Psychiatry 2013, 170:462-465.
5. Jabrocka-Hybel A., Skalniak, Piatkowski J., Pach D., Hubalewska-Dydejczyk How far are we from understanding the genetic basis of Hashimoto's thyroiditis?. Int Rev Immunol 2013, 10.3109/08830185.2012.755175.
6. Boyle A.P., Hong E.L., Hariharan M., Cheng Y., Schaub M.A., Kasowski M., Karczewski K.J., Park J., Hitz B.C., Weng S., Cherry J.M., Snyder M. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012, 22:1790-1797.
7. Zanker K.S., Mihich E., Huber H.-P., Li A. Personalized cancer care conference. J Personal Med 2013, 2:70-81.
8. Werayingyong P., Tosanguan K., Butchon R., Phanuphak N., Chokephaibulkit K., Kullert N., Teerawattananon Y., Tantivess S. The feasibility study on introducing three-antiretroviral combinations as standard regimens for prevention of mother to child HIV transmission in Thailand. J Health Sci 2013, 22:99-112.
9. Loffredo F.S., Steinhauser M.L., Jay S.M., Gannon J., Pancoast J.R., Yalamanchi P., Sinha M., Dall'Osso C., Khong D., Shadrach J.L., Miller C.M., Singer B.S., Stewart A., Psychogios N., Gerszten R.E., Hartigan A.J., Kim M.-J., Serwold T., Wagers A.J., Lee R.T. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 2013, 153:828-839.
10. Capecchi M.R. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 2005, 6:507-512.
11. Hokibara S., Takamoto M., Tominaga A., Takatsu K., Sugane K. Marked eosinophilia in interleukin-5 transgenic mice fails to prevent Trichinella spiralis infection. J Parasitol 1997, 83:1186-1189.
12. Fabre V., Beiting D.P., Bliss S.K., Gebreselassie N.G., Gagliardo L.F., Lee N.A., Lee J.J., Appleton J.A. Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol 2009, 182:1577-1583.
13. Shultz L.D., Brehm M.A., Garcia-Martinez J.V., Greiner D.L. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 2012, 12:786-798.
14. Huang C-j, Lowe A.J., Batt C.A. Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market. Appl Microbiol Biotechnol 2010, 87:401-410.
15. Rappuoli R., Black S., Lambert P.H. Vaccine discovery and translation of new vaccine technology. Lancet 2011, 378:360-368.
16. Długońska H., Grzybowski M. Mucosal vaccination: an old but still vital strategy. Ann Parasitol 2012, 58:1-8.
17. Ulmer J.B., Wahren B., Liu M.A. Gene-based vaccines: recent technical and clinical advances. Trends Mol Med 2006, 12:216-222.
18. Lössl A.G., Waheed M.T. Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes. Plant Biotechnol J 2011, 9:527-539.
19. Guan Z-j, Guo B., Huo Y.-l, Guan Z-p, Dai Y-k, Wei Y-h. Recent advances and safety issues of transgenic plant-derived vaccines. Appl Microbiol Biotechnol 2013, 97:2817-2840.
20. Nandedkar T.D. Nanovaccines: recent developments in vaccination. J Biosci 2009, 34:995-1003.
21. Burridge S. Drugging the epigenome. Nat Rev Drug Discov 2013, 12:92-93.
22. Arrowsmith C.H., Boutra C., Fish P.V., Lee K., Schapira M. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 2012, 11:384-400.
23. Schenk T., Chen W.C., Göllner S., Howell L., Jin L., Hebestreit K., Klein H.U., Popescu A.C., Burnett A., Mills K., Casero R.A., Marton L., Woster P., Minden M.D., Dugas M., Wang J.C., Dick J.E., Müller-Tidow C., Petrie K., Zelent A., Zelent A. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukaemia. Nat Med 2012, 18:605-611.
24. Obama B. State of the Union Address 2013.
25. Kaur J.S., Petereit DG Personalized medicine: challenge and promise. J Cancer Educ 2012, 27(s1):12-17.
26. Hegde M.R. Marching towards personalized genomic medicine. J Pediatrics 2013, 162:10-11.
27. Dauber A., Stoler J., Hechter E., Safer J., Hirschhorn J.N. Whole exome sequencing reveals a novel mutation in CUL7 in a patient with an undiagnosed growth disorder. J Pediatrics 2013, 162:202-204.
28. Shute N. Personalised medicine. Sci Am 2012, 306:44.
29. Harvey A., Brand A., Holgate S.T., Kristiansen L.V., Lehrach H., Palotie A., Prainsack B. The future of technologies for personalised medicine. New Biotechnol 2012, 29:625-633.
30. Li-Wan-Po A., Farndon P. Barking up the wrong genome - we are not alone. J Clin Pharm Ther 2012, 36:125-127.
31. Monteiro T.P., El-Jaick K.B., Jeovanio-Silva A.L., Brasil P.E., Costa M.J., Rolla V.C., de Castro L. The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug induced liver injury. J Clin Pharm Ther 2012, 37:712-718.
32. Stahl S.M. Psychotherapy as an epigenetic drug. J Clin Pharm Ther 2012, 37:249-253.
33. Peedicayli J. Role of epigenetics in pharmacotherapy, psychotherapy and nutritional management of mental disorders. J Clin Pharm Ther 2012, 37:499-501.
34. Jones S. A snapshot of the microbiome field. Nat Biotechnol 2013, 31:282-283.
35. Jayaseelan S., Tenenbaum S.A. Signalling pathways of fragile X syndrome. Nature 2012, 492:359-360.
36. Wilusz J.E., Shap P.A. A circuitous route to noncoding RNA. Science 2013, 340:440-441.
37. Gahan P.B. Circulating nucleic acids in plasma and serum: applications in diagnostic techniques for non-invasive prenatal diagnosis. Int J Women's Health 2013, 5:177-186.
38. Tsui N.B., Kadir R.A., Chan K.C., Chi C., Mellars G., Tuddenham E.G., Leung T.Y., Lau T.K., Chiu R.W., Lo Y.M. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 2011, 117:3684-3691.
39. Barrett A.N., McDonnell T.C., Chan K.C., Chitty L.S. Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem 2012, 58:1026-1032.
40. McKenna M. Shock to the system: researchers struggle to develop new treatments for sepsis. Sci Am 2013, 308:30-32.
41. Cooper R. The battle to discover new antibiotics. Telegraph 2012, http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/9010738/The-battle-to-discover-new-antibiotics.html.
42. Butler M., Cooper M. New antibiotics: what's in the pipeline?. Conversation 2012.
43. Huang T.D., Berhin C., Bogaerts P., Glupczynski Y. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium. J Antimicrobial Chemother 2013, 10.1093/jac/dkt096.
44. Moir D.T., Opperman T.J., Butler M.M., Bowlin T. New classes of antibiotics. Curr Opin Pharmacol 2012, 12:535-544.
45. Garmendia L., Hernandez A., Sanchez M.B., Martinez L. Metagenomics and antibiotics. Clin Microbiol Infect 2012, 18:27-31.
46. Chung K., Wallace J., Kim S.-Y., Kalyanasundaram S., Andalmn A.S. Structural and molecular interrogation of intact biological systems. Nature 2013, 10.1038/nature12107.
47. Parr C. At the heart of the higher education debate: Obama's research boost welcomed by US universities. Times Higher Education 2013.
48. Baker M. Gene editing nucleases. Nat Methods 2012, 9:23-26.
49. Lei Y., Lee C.L., Joo K.I., Zarzar J., Liu Y., Dai B., Fox V., Wang P. Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases. Mol Ther 2011, 19:942-950.
50. Papaioannou I., Simons J.P., Owen J.S. Oligonucleotide-directed gene-editing technology: mechanisms and future prospects. Expert Opin Biol Ther 2012, 12:329-342.
51. Chang N., Changhong S., Gao L., Zhu D., Xu X., Zhu X., Xiong J.-W., Xi J.J. Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos. Cell Res 2013, 23:465-472.
52. Joung J.K., Sander J.D. TALENS: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 2013, 14:49-55.
53. Cermak T., Doyle E.L., Christian M., Wang L., Zhang Y., Schmidt C., Baller J.A., Somia N.V., Bogdanove A.J., Voytas D.F. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 2011, 39:e82.
54. Ledford L. Targeted gene editing enters clinic. Nature 2011, 471:16.
55. Allers K., Hutter G., Hofmann J., Loddenkemper C., Rieger K., Thiel E., Schneider T. Evidence for the cure of HIV infection by CCR5δ32/δ32 stem cell transplantation. Blood 2011, 117:2791-2799.
56. WhyteJJ, Prather R.S. Cell Biology Symposium: zinc-finger nucleases to create custom-designed modifications in the swine (Sus scrofa) genome. J Anim Sci 2012, 90:1111-1117.
57. USFDA FDA Extends Comment Period on Aqua-Advantage Salmon Documents 2013, http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm339270.htm.
58. DEFRA (UK) Method verification of the LOD associated with the DEFRA/FSA study protocol for the detection of horse DNA in food samples. DEFRA Research Report 2013, FAO134.
59. Arun O.O., Yilmaz F., Muratogolu K. PCR detection of genetically modified maize and soy in mildly and highly processed foods. Food Control 2013, 32:525-531.
60. Kamle S., Ali S. Genetically modified crops: detection strategies and biosafety issues. Gene 2013, ht*tp://dx.doi.org/10.1016/j.gene.2013.107.
61. Anonymous GM crops: a story in numbers. Nature 2013, 497:22-23.
62. Fermin G., Keith R.C., Suzuki J.Y., Ferreira S.A., Gaskil D.A., Pitz K.Y., Manshardt R.M., Gonsalves D., Tripathi S. Allergenicity assessment of the papaya ringspot virus coat protein expressed in transgenic rainbow papya. J Agric Food Chem 2011, 59:10006-10012.
63. Abbas Z., Zafar Y., Khan S.A., Mukhtar Z. A chimeric protein encoded by synthetic genes shows toxicity to Helicoverpa armigera and Spodotera littoralis larvae. Int J Agric Biol 2013, 15:325-330.
64. Sharma V.K., Sanghera G.S., Kashyap P.L., Sharma B.B., Chandel C. RNA interference: a novel tool for plant disease management. African J Biotechnol 2013, 12:2303-2312.
65. Wu H.-J., Wang Z.-M., Wang M., Wang X.-J. Wide-spread long non-coding RNAs (IncRNAs) as endogenous target mimics (eTMs) for microRNAs in plants. Plant Physiol 2013, h*ttp://dx.doi.org/10.1104/pp.113.215962.
66. Chen Q., Tao S., Bi X., Xu X., Wang L., Li X. Research progress in physiological and molecular biology mechanism of drought resistance in rice. Am J Mol Biol 2013, 3:102-107.
67. Strauss S.H., Viswanath V. Field trials of GM trees in the USA: activity and regulatory environments. BMC Proc 2011, 5(s7):061.
68. Arborgen Freeze Tolerant Eucalyptus 2011, http://www.arborgen.us/index.php/products/product-pipeline/freeze-tolerant-eucalyptus.
69. Bonawitz N.D., Chapple C. Can genetic engineering of lignin deposition be accomplished without an unacceptable yield penalty?. Curr Opin Biotechnol 2013, 24:336-343.
70. Patrascoiu M., Rathbauer J., Negrea M., Zeller R. Perspectives of safflower oil as a biodiesel source for South Eastern Europe (comparative study: safflower, soybean and rapeseed). Fuel 2013, ht*tp://dx.doi.org/10.1016/j.fuel.2013.04.012.
71. López J.A., Naranjo J.M., Higuita J.C., Cubitto M.A., Cardona C.A., Villar M.A. Biosynthesis of PHB from a new isolated Bacillus megaterium strain: outlook on future developments with endospore forming bacteria. Biotechnol Bioprocess Eng 2012, 17:250-258.
72. Pan W., Perrotta J.A., Stipanovic A.J., Nomura C.T., Nakas J.P. Production of polyhydroxyalkanoates by Burkholderia cepacia ATCC 17759 using a detoxified sugar maple hemicellulosic hydrolysate. J Ind Microbiol Biotechnol 2012, 39:459-469.
73. Schnell J.A., Treyvaud-Amiguet V., Arnason J.T., Johnson D.A. Expression of polyhydroxybutyric acid as a model for metabolic engineering of soybean seed coats. Transgenic Res 2012, 21:895-899.
74. Su T.-T., Lin C.-W., Y-P I., Wu C.-H. Biodegradation of semiconductor volatile organic compounds by four novel bacterial strains: a kinetic analysis. Bioprocess Biosyst Eng 2012, 35:1117-1124.
75. Nielsen P.H., Mielczerek A.T., Kragelund C., Nielsen J.L., Saunders A.M., Kong Y., Hansen A.A., Vollertsen J. A conceptual ecosystem model of microbial communities in enhanced biological phosphorous removal plants. Water Res 2010, 44:5070-5088.
76. Albertsen M., Hansen L.B.S., Saunders A.M., Nielsen P.H., Nielsen K.L. A metagenome of a full-scale microbial community carrying out enhanced biological phosphorous removal. ISME J 2012, 6:1094-1106.
77. Nielsen P.H., Saunders A.M., Hansen A.A., Larsen P., Nielsen J.L. Microbial communities involved in enhanced biological phosphorus removal from wastewater - a model system in environmental biotechnology. Curr Opin Biotechnol 2012, 23:452-459.
78. Salwan R., Chand R. Purification and characterisation of an extracellular low temperature-active and alkaline stable peptidase from psychotrophic Acinetobacter sp., MN12 MTCC (10786). Ind J Microbiol 2013, 53:63-69.
79. Palma-Rodriguez H.M., Agama-Acevedo E., Gonzalez-Soto R.A., Vernon-Carter E.J., Alvarez-Ramirez J., Bello-Perez L.A. Ascorbic acid microencapsulation by spray-drying in native and acid-modified starches from different botanical sources. Starch J 2013, 10.1002/star.201200200.
80. Jubril I., Muazu J., Mohammed G.T. Effects of phosphate modified and pregelatinized sweet potato starches on disintegrant property of paracetamol tablet formulations. J Appl Pharmaceut Sci 2012, 32-36.